Global Rivaroxaban Market Growth 2021-2026

  • receipt Report ID : 261118
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Rivaroxaban will have significant change from previous year. By the most conservative estimates of global Rivaroxaban market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 7356.9 million in 2020. Over the next five years the Rivaroxaban market will register a 8.5% CAGR in terms of revenue, the global market size will reach US$ 10200 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

2.5 mg

10 mg

15 mg

20 mg

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Acute Coronary Syndrome (ACS)

Venous Thromboembolism (VTE)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Bayer

J&J

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rivaroxaban Consumption 2016-2026

2.1.2 Rivaroxaban Consumption CAGR by Region

2.2 Rivaroxaban Segment by Type

2.2.1 2.5 mg

2.2.2 10 mg

2.2.3 15 mg

2.2.4 20 mg

2.3 Rivaroxaban Sales by Type

2.3.1 Global Rivaroxaban Sales Market Share by Type (2016-2021)

2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2016-2021)

2.3.3 Global Rivaroxaban Sale Price by Type (2016-2021)

2.4 Rivaroxaban Segment by Application

2.4.1 Acute Coronary Syndrome (ACS)

2.4.2 Venous Thromboembolism (VTE)

2.5 Rivaroxaban Sales by Application

2.5.1 Global Rivaroxaban Sale Market Share by Application (2016-2021)

2.5.2 Global Rivaroxaban Revenue and Market Share by Application (2016-2021)

2.5.3 Global Rivaroxaban Sale Price by Application (2016-2021)

3 Global Rivaroxaban by Company

3.1 Global Rivaroxaban Sales Market Share by Company

3.1.1 Global Rivaroxaban Sales by Company (2019-2021)

3.1.2 Global Rivaroxaban Sales Market Share by Company (2019-2021)

3.2 Global Rivaroxaban Revenue Market Share by Company

3.2.1 Global Rivaroxaban Revenue by Company (2019-2021)

3.2.2 Global Rivaroxaban Revenue Market Share by Company (2019-2021)

3.3 Global Rivaroxaban Sale Price by Company

3.4 Global Manufacturers Rivaroxaban Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Rivaroxaban Product Location Distribution

3.4.2 Players Rivaroxaban Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Rivaroxaban by Region

4.1 Global Rivaroxaban by Region

4.1.1 Global Rivaroxaban Sales by Region

4.1.2 Global Rivaroxaban Revenue by Region

4.2 Americas Rivaroxaban Sales Growth

4.3 APAC Rivaroxaban Sales Growth

4.4 Europe Rivaroxaban Sales Growth

4.5 Middle East & Africa Rivaroxaban Sales Growth

5 Americas

5.1 Americas Rivaroxaban Sales by Country

5.1.1 Americas Rivaroxaban Sales by Country (2016-2021)

5.1.2 Americas Rivaroxaban Revenue by Country (2016-2021)

5.2 Americas Rivaroxaban Sales by Type

5.3 Americas Rivaroxaban Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rivaroxaban Sales by Region

6.1.1 APAC Rivaroxaban Sales by Region (2016-2021)

6.1.2 APAC Rivaroxaban Revenue by Region (2016-2021)

6.2 APAC Rivaroxaban Sales by Type

6.3 APAC Rivaroxaban Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Rivaroxaban by Country

7.1.1 Europe Rivaroxaban Sales by Country (2016-2021)

7.1.2 Europe Rivaroxaban Revenue by Country (2016-2021)

7.2 Europe Rivaroxaban Sales by Type

7.3 Europe Rivaroxaban Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rivaroxaban by Country

8.1.1 Middle East & Africa Rivaroxaban Sales by Country (2016-2021)

8.1.2 Middle East & Africa Rivaroxaban Revenue by Country (2016-2021)

8.2 Middle East & Africa Rivaroxaban Sales by Type

8.3 Middle East & Africa Rivaroxaban Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Rivaroxaban Distributors

10.3 Rivaroxaban Customer

11 Global Rivaroxaban Market Forecast

11.1 Global Rivaroxaban Forecast by Region

11.1.1 Global Rivaroxaban Forecast by Regions (2021-2026)

11.2.2 Global Rivaroxaban Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Rivaroxaban Forecast by Type

11.7 Global Rivaroxaban Forecast by Application

12 Key Players Analysis

12.1 Bayer

12.1.1 Bayer Company Information

12.1.2 Bayer Rivaroxaban Product Offered

12.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Bayer Main Business Overview

12.1.5 Bayer Latest Developments

12.2 J&J

12.2.1 J&J Company Information

12.2.2 J&J Rivaroxaban Product Offered

12.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 J&J Main Business Overview

12.2.5 J&J Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Rivaroxaban Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of 2.5 mg

Table 3. Major Players of 10 mg

Table 4. Major Players of 15 mg

Table 5. Major Players of 20 mg

Table 6. Global Rivaroxaban Sales by Type (2016-2021) & (M Units)

Table 7. Global Rivaroxaban Sales Market Share by Type (2016-2021)

Table 8. Global Rivaroxaban Revenue by Type (2016-2021) & ($ million)

Table 9. Global Rivaroxaban Revenue Market Share by Type (2016-2021)

Table 10. Global Rivaroxaban Sale Price by Type (2016-2021)

Table 11. Global Rivaroxaban Sales by Application (2016-2021) & (M Units)

Table 12. Global Rivaroxaban Sales Market Share by Application (2016-2021)

Table 13. Global Rivaroxaban Value by Application (2016-2021)

Table 14. Global Rivaroxaban Revenue Market Share by Application (2016-2021)

Table 15. Global Rivaroxaban Sale Price by Application (2016-2021)

Table 16. Global Rivaroxaban Sales by Company (2019-2021) & (M Units)

Table 17. Global Rivaroxaban Sales Market Share by Company (2019-2021)

Table 18. Global Rivaroxaban Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Rivaroxaban Revenue Market Share by Company (2019-2021)

Table 20. Global Rivaroxaban Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Rivaroxaban Producing Area Distribution and Sales Area

Table 22. Players Rivaroxaban Products Offered

Table 23. Rivaroxaban Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Rivaroxaban Sales by Region (2016-2021) (M Units)

Table 27. Global Rivaroxaban Sales Market Share by Region (2016-2021)

Table 28. Global Rivaroxaban Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Rivaroxaban Revenue Market Share by Region (2016-2021)

Table 30. Americas Rivaroxaban Sales by Country (2016-2021) & (M Units)

Table 31. Americas Rivaroxaban Sales Market Share by Country (2016-2021)

Table 32. Americas Rivaroxaban Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Rivaroxaban Revenue Market Share by Country (2016-2021)

Table 34. Americas Rivaroxaban Sales by Type (2016-2021) & (M Units)

Table 35. Americas Rivaroxaban Sales Market Share by Type (2016-2021)

Table 36. Americas Rivaroxaban Sales by Application (2016-2021) & (M Units)

Table 37. Americas Rivaroxaban Sales Market Share by Application (2016-2021)

Table 38. APAC Rivaroxaban Sales by Region (2016-2021) & (M Units)

Table 39. APAC Rivaroxaban Sales Market Share by Region (2016-2021)

Table 40. APAC Rivaroxaban Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Rivaroxaban Revenue Market Share by Region (2016-2021)

Table 42. APAC Rivaroxaban Sales by Type (2016-2021) & (M Units)

Table 43. APAC Rivaroxaban Sales Market Share by Type (2016-2021)

Table 44. APAC Rivaroxaban Sales by Application (2016-2021) & (M Units)

Table 45. APAC Rivaroxaban Sales Market Share by Application (2016-2021)

Table 46. Europe Rivaroxaban Sales by Country (2016-2021) & (M Units)

Table 47. Europe Rivaroxaban Sales Market Share by Country (2016-2021)

Table 48. Europe Rivaroxaban Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Rivaroxaban Revenue Market Share by Country (2016-2021)

Table 50. Europe Rivaroxaban Sales by Type (2016-2021) & (M Units)

Table 51. Europe Rivaroxaban Sales Market Share by Type (2016-2021)

Table 52. Europe Rivaroxaban Sales by Application (2016-2021) & (M Units)

Table 53. Europe Rivaroxaban Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Rivaroxaban Sales by Country (2016-2021) & (M Units)

Table 55. Middle East & Africa Rivaroxaban Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Rivaroxaban Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Rivaroxaban Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Rivaroxaban Sales by Type (2016-2021) & (M Units)

Table 59. Middle East & Africa Rivaroxaban Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Rivaroxaban Sales by Application (2016-2021) & (M Units)

Table 61. Middle East & Africa Rivaroxaban Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Rivaroxaban

Table 63. Key Application and Potential Industries of Rivaroxaban

Table 64. Key Challenges of Rivaroxaban

Table 65. Key Trends of Rivaroxaban

Table 66. Rivaroxaban Distributors List

Table 67. Rivaroxaban Customer List

Table 68. Global Rivaroxaban Sales Forecast by Region (2021-2026) & (M Units)

Table 69. Global Rivaroxaban Consumption Market Forecast by Region

Table 70. Global Rivaroxaban Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Rivaroxaban Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Rivaroxaban Sales Forecast by Country (2021-2026) & (M Units)

Table 73. Americas Rivaroxaban Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Rivaroxaban Sales Forecast by Region (2021-2026) & (M Units)

Table 75. APAC Rivaroxaban Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Rivaroxaban Sales Forecast by Country (2021-2026) & (M Units)

Table 77. Europe Rivaroxaban Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Rivaroxaban Sales Forecast by Country (2021-2026) & (M Units)

Table 79. Middle East & Africa Rivaroxaban Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Rivaroxaban Sales Forecast by Type (2021-2026) & (M Units)

Table 81. Global Rivaroxaban Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Rivaroxaban Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Rivaroxaban Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Rivaroxaban Sales Forecast by Application (2021-2026) & (M Units)

Table 85. Global Rivaroxaban Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Rivaroxaban Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Rivaroxaban Revenue Market Share Forecast by Application (2021-2026)

Table 88. Bayer Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors

Table 89. Bayer Rivaroxaban Product Offered

Table 90. Bayer Rivaroxaban Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 91. Bayer Main Business

Table 92. Bayer Latest Developments

Table 93. J&J Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors

Table 94. J&J Rivaroxaban Product Offered

Table 95. J&J Rivaroxaban Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 96. J&J Main Business

Table 97. J&J Latest Developments

List of Figures

Figure 1. Picture of Rivaroxaban

Figure 2. Rivaroxaban Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Rivaroxaban Sales Growth Rate 2016-2026 (M Units)

Figure 7. Global Rivaroxaban Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Rivaroxaban Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of 2.5 mg

Figure 10. Product Picture of 10 mg

Figure 11. Product Picture of 15 mg

Figure 12. Product Picture of 20 mg

Figure 13. Global Rivaroxaban Sales Market Share by Type in 2020

Figure 14. Global Rivaroxaban Revenue Market Share by Type (2016-2021)

Figure 15. Rivaroxaban Consumed in Acute Coronary Syndrome (ACS)

Figure 16. Global Rivaroxaban Market: Acute Coronary Syndrome (ACS) (2016-2021) & (M Units)

Figure 17. Rivaroxaban Consumed in Venous Thromboembolism (VTE)

Figure 18. Global Rivaroxaban Market: Venous Thromboembolism (VTE) (2016-2021) & (M Units)

Figure 19. Global Rivaroxaban Sales Market Share by Application (2016-2021)

Figure 20. Global Rivaroxaban Revenue Market Share by Application in 2020

Figure 21. Rivaroxaban Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Rivaroxaban Revenue Market Share by Company in 2020

Figure 23. Global Rivaroxaban Sales Market Share by Regions (2016-2021)

Figure 24. Global Rivaroxaban Revenue Market Share by Region in 2020

Figure 25. Americas Rivaroxaban Sales 2016-2021 (M Units)

Figure 26. Americas Rivaroxaban Revenue 2016-2021 ($ Millions)

Figure 27. APAC Rivaroxaban Sales 2016-2021 (M Units)

Figure 28. APAC Rivaroxaban Revenue 2016-2021 ($ Millions)

Figure 29. Europe Rivaroxaban Sales 2016-2021 (M Units)

Figure 30. Europe Rivaroxaban Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Rivaroxaban Sales 2016-2021 (M Units)

Figure 32. Middle East & Africa Rivaroxaban Revenue 2016-2021 ($ Millions)

Figure 33. Americas Rivaroxaban Sales Market Share by Country in 2020

Figure 34. Americas Rivaroxaban Revenue Market Share by Country in 2020

Figure 35. Americas Rivaroxaban Sales Market Share by Type in 2020

Figure 36. Americas Rivaroxaban Sales Market Share by Application in 2020

Figure 37. United States Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Rivaroxaban Sales Market Share by Region in 2020

Figure 42. APAC Rivaroxaban Revenue Market Share by Regions in 2020

Figure 43. APAC Rivaroxaban Sales Market Share by Type in 2020

Figure 44. APAC Rivaroxaban Sales Market Share by Application in 2020

Figure 45. China Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Rivaroxaban Sales Market Share by Country in 2020

Figure 52. Europe Rivaroxaban Revenue Market Share by Country in 2020

Figure 53. Europe Rivaroxaban Sales Market Share by Type in 2020

Figure 54. Europe Rivaroxaban Sales Market Share by Application in 2020

Figure 55. Germany Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Rivaroxaban Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Rivaroxaban Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Rivaroxaban Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Rivaroxaban Sales Market Share by Application in 2020

Figure 64. Egypt Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Rivaroxaban Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Please fill the form below, to recieve the report sample


+1